Episodes
Friday Nov 08, 2024
A Broken Heart: Empagliflozin Falls Flat after Acute Myocardial Infarction
Friday Nov 08, 2024
Friday Nov 08, 2024
Despite advances in the management of acute myocardial infarction (MI), up to 38% of patients will experience signs of heart failure (HF) and many have a reduced left ventricular ejection fraction (LVEF). Sodium-glucose cotransporter 2 (SGLT2) inhibitors have well-documented cardiovascular benefits. However, data are limited regarding their use after an acute MI.
Guest Authors: Amy Hu, PharmD and Kathleen Pincus, PharmD, BCPS, BCACP, CDCES
Music by Good Talk
Friday Oct 25, 2024
Friday Oct 25, 2024
One of the most debilitating aspects of dementia is the behavioral and psychological symptoms of dementia (BPSD) that impact nearly 90% of patients. These symptoms significantly diminish the quality of life and functional abilities of those affected. To combat the most severe of these symptoms, antipsychotic medications are often prescribed, but not without possibly harmful consequences. A new study sheds additional light on these detrimental consequences.
Guest Authors: Melissa C. Palmer, PharmD, BCPS, BCPP and Jessa Marie Koch, PharmD, APh, BCPP
Music by Good Talk
Friday Oct 04, 2024
Get Quit, Stay Quit! Smoking Cessation After Initial Treatment Failure
Friday Oct 04, 2024
Friday Oct 04, 2024
It is still difficult for patients to quit despite their best efforts. Of the nearly 70% of current smokers who want to quit smoking, only about 7.5% succeed. Unfortunately, there is a lack of evidence to inform subsequent treatment strategies if the initial quit attempt is unsuccessful.
Guest Authors: Elizabeth Yett, PharmD, BCACP, TTS and Katherine Montag Schafer, PharmD, BCACP, CDCES
Music by Good Talk
Friday Sep 27, 2024
Complex Patient Case 7: Post CABG but not on a statin ... oh my!
Friday Sep 27, 2024
Friday Sep 27, 2024
Reason for Visit: The patient is a 76-year-old Hispanic referred to the ambulatory care pharmacist for dyslipidemia management. The patient has a remote history of an MI (15 years ago) but states he is unable to take statins.
Guest Authors: Mayela Warner, PharmD and Maricar Conson, PharmD, BCPS
Expert Panelists: Sara Wettergreen, PharmD, BCACP, BC-ADM and Tomasz Jurga, PharmD, BCPS, BCACP, BCCP, CDCES
Music by Good Talk
Friday Sep 13, 2024
Semaglutide for CKD – Does the FLOW trial impact the standard of care?
Friday Sep 13, 2024
Friday Sep 13, 2024
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are one of the established treatments used to slow the progression of CKD and improve outcomes. Could perhaps the glucagon-like peptide 1 (GLP-1) receptor agonists provide similar, additive, or different benefits in patients with CKD?
Guest Author: John Swegle, PharmD, BCPS, BCACP
Music by Good Talk
Tuesday Sep 03, 2024
“We’ed” Better Work Together to Address Cannabis Use in Pregnancy
Tuesday Sep 03, 2024
Tuesday Sep 03, 2024
Over the last several decades, the popularity of cannabis (aka marijuana, weed) has increased significantly, and the recognition of medical benefits is evolving. Cannabis is often celebrated in popular culture as a relaxation-promoting, pain-relieving, harmless substance, and its use among young adults and pregnant women is increasing steadily. A recently published ancillary analysis of the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be (nuMoM2b) aimed to characterize the association between maternal cannabis use and adverse pregnancy outcomes.
Guest Author: Courtney Cameron, PharmD, BCACP
Special Guest: Leah Sera, PharmD, MA, BCPS
Music by Good Talk
Wednesday Aug 28, 2024
Remote Patient Monitoring (RPM): The Promise and Pitfalls
Wednesday Aug 28, 2024
Wednesday Aug 28, 2024
This episode is a collaboration between the ACCP Ambulatory Care Practice and Research Network (PRN) ... and iForumRx.org.
We speak with three panelists who describe the use of remote patient monitoring within their cardiology practices. From measuring weight, blood pressure, heart rate, blood glucose, and even pulmonary artery pressure, the use of remote patient monitoring devices has the potential to revolutionize patient care by making more data available "real-time" and engaging patients more in their care. Nonetheless, there are significant barriers too.
Panelists: Christine Cadiz PharmD, BCPS; Rachel Klosko, PharmD, BCCP, and Aimon Miranda, PharmD, BCPS
Produced by Rebecca Khaimova, PharmD, BCACP, CDCES and Anna K Love, PharmD, BCACP
Music by lemonmusicstudio from Pixabay
Friday Aug 16, 2024
Friday Aug 16, 2024
It is now uncommon to see warfarin therapy initiated for stroke prevention. However, quality patient care is never a “one-size-fits-all” approach. New evidence from the FRAIL-AF trial suggests that some of our most vulnerable older adults might be better off maintained on a vitamin K antagonist rather than (automatically) switched to a direct oral anticoagulation (DOAC).
Guest Author: Matthew Cantrell, PharmD, BCPS
Music by Good Talk
Friday Aug 02, 2024
Complex Patient Case 6: Multiple Comorbidities and Too Many Meds
Friday Aug 02, 2024
Friday Aug 02, 2024
Reason for Visit: Patient presents today for routine follow-up in the heart failure clinic to optimize his medications.
Guest Authors: Jushua W. Skaggs, PharmD, and Jessica Wooster Thomas, PharmD, BCACP
Expert Panelists: Kristin Watson, PharmD, MS, BCCP and Robert DiDomenico, PharmD
Music by Good Talk
Friday Jul 19, 2024
Weighing Options: Comparing Oral Anticoagulants for Patients at Various BMIs
Friday Jul 19, 2024
Friday Jul 19, 2024
Direct oral anticoagulants (DOACs) are the standard of care for stroke prevention in most patients with nonvalvular atrial fibrillation (NVAF). Data on the safety and efficacy of DOACS in patients with obesity are limited and, at times, contradictory. What would you recommend for a patient with a BMI>40: warfarin, which requires periodic monitoring and dose adjustments, or a DOAC, which may not be as effective?
Guest Authors: Taylor M. Benavides, PharmD, BCPS and Elizabeth B. Hearn, PharmD, BCACP
Music by Good Talk